Publication | Closed Access

Phase I-II trial of twice-weekly gemcitabine and concomitant irradiation in patients undergoing pancreaticoduodenectomy with extended lymphadenectomy for locally advanced pancreatic cancer

Phase I-ii TrialSurgical OncologyPancreatic CancerRadiation TherapyGastrointestinal OncologyMedicineSurgeryAdvanced Pancreatic CancerOncologyRadiation OncologyTwice-weekly Gemcitabine